Low concentration of bioactive moranolin in native biological sources limits industrial scalability. Increasing production efficiency overcomes the bottleneck of high extraction costs and low supply consistency.

Uncontrolled melanin overproduction and therapeutic evasion in melanocytes. Addressing these failures restores skin homeostasis and treatment efficacy.

Hyperpigmentation and uneven skin tone result from uncontrolled melanogenesis. Reducing these pigmentary deposits restores aesthetic uniformity and prevents localized skin darkening.